Back to List View Graph View

Reactive oxygen species

Reactive oxygen species (ROS) are chemically reactive, oxygen-derived molecules and radicals, including superoxide, hydrogen peroxide, hydroxyl radical, and singlet oxygen.

Where the papers sit

34 papers from the last 6 months study reactive oxygen species directly · updated from PubMed 16 Nov 2026

Study type 0 clinical trials · 2 human data · 31 preclinical · 1 unclassified

Themes 5 themes · 1 paradigm shift

  • ROS-Responsive Nanomedicine

    ROS-responsive nanomedicine is moving toward treatment that combines deep-tissue activation, imaging and feedback rather than relying on passive drug release. X-ray, near-infrared and ultrasound-triggered platforms generate hydroxyl radicals or release paclitaxel for tumors, while MOFs and cobalt particles target inflammatory disease. Thioketal chemistry, oxygen vacancies and ROS-triggered hydrogel disassembly provide control over release and tissue barriers. Imaging-guided precision, safety and performance across cancer, cornea, bowel and kidney injury remain open questions.

    9 papers · 26.5%

  • Redox Regulation Across Disease

    Redox regulation is being linked to ferroptosis, metabolic disease, cancer drug resistance, inflammation and pain rather than treated as a single pathway. NRF2 activation, lipid and mitochondrial control, and NOX4/ROS/NLRP3 signaling recur alongside efforts to force ROS accumulation, as with p-coumaric acid or cryptotanshinone. HIF1α-KLF4-driven hemoglobin expression and EGFR/ROS signaling connect redox state to sorafenib resistance and glioma ferroptosis. The opposing use of antioxidants and pro-oxidant therapy leaves context-specific treatment selection unresolved.

    8 papers · 23.5%

  • ROS-Based Cancer and Infection Therapy

    ROS-generating nanomaterials are being developed to kill tumor cells and antibiotic-resistant bacteria while improving delivery through solid tissue. AIE photosensitizers and organelle-targeted systems couple ROS production to lysosomal autophagy, apoptosis, DNA damage, or broad-spectrum photodynamic killing. Combination effects include santamarine with cisplatin. Mitophagy-mediated ROS suppression emerges as a route to gemcitabine resistance, leaving selective activation and resistance control open.

    7 papers · 20.6%

  • Antioxidant Nanotherapy for Oxidative Stress

    Antioxidant nanotherapies are being tailored to restore redox balance in bone, joint, neural, pulmonary and neurodegenerative disease. Mn3O4 nanozymes, carbon-dot nanoreactors, peptide hydrogels and self-assembled fibers localize ROS scavenging or drug release to mitochondria, bone or injured tissue. The recurring aim is to reduce inflammation and oxidative damage while enabling regeneration, including neurite outgrowth and bone remodeling. Translation beyond localized preclinical disease remains open.

    6 papers · 17.6%

  • Smart Therapy for Diabetic Wounds

    Diabetic wound treatment is converging on responsive platforms that combine biofilm eradication with antioxidant and anti-inflammatory repair. Cross-linked hydrogels, chitosan microspheres and microneedle patches pair antibacterial or photodynamic action with modulation of the wound microenvironment. GSH scavenging and synthesis blockade strengthen photodynamic killing, while stage-specific delivery addresses changing wound biology. The direction is toward coordinated, sequential therapy rather than single-function dressings.

    4 papers · 11.8%

PARADIGM SHIFT

In cancer, ROS scavenging can drive treatment resistance rather than protect against it

Hepatocellular carcinoma treated with sorafenib and gallbladder cancer made resistant to gemcitabine were each assumed to benefit from mechanisms that suppress damaging ROS, but the studies found that tumor-intrinsic ROS removal instead supported resistance: HIF1α–KLF4-induced extra-erythrocytic hemoglobin scavenged ROS and promoted sorafenib resistance in hepatocellular carcinoma 42744801Sep, while enhanced mitophagy maintained abnormally low ROS and drove gemcitabine resistance in gallbladder cancer 42716921Sep. Together, these findings recast ROS reduction from an unqualified protective strategy as a cancer-cell adaptation that can preserve malignant cells under therapy, making disruption of the scavenging or low-ROS state a potential treatment objective.

Papers

The 34 papers from the last 6 months that study reactive oxygen species directly, newest first, by theme and by study type. Study types come from PubMed publication types and MeSH headings.

By theme

ROS-Responsive Nanomedicine (9)
  1. Ultrasmall Ag₂Se@Mn quantum dots enable dual-modal imaging-guided early detection and antioxidant therapy of acute kidney injury. Mikrochimica acta · 7 Sept 2026 PMID 42704498
  2. Multiphoton imaging-guided and feedback-enabled anti-inflammatory therapy over MOF nanoplatforms. Journal of materials chemistry. B · 1 Sept 2026 PMID 42676025
  3. ROS-Triggered Disassembly of Nanoparticle-Networked Hydrogels Enables Dynamic Gating of Corneal Tight Junctions. ACS applied materials & interfaces · 13 Aug 2026 PMID 42587441
  4. Nitric Oxide-Releasing Molecular Co-Assembly Enables Epithelial-Mesenchymal Transition Suppression and Intermolecular Electron Transfer-Enhanced Type-I Photodynamic Therapy. ACS nano · 11 Aug 2026 PMID 42579410
  5. Near-infrared light-triggered, self-amplifying targeted drug-delivery platform achieves precision treatment of retinoblastoma. International journal of pharmaceutics · 10 Jun 2026 PMID 42269794
  6. Oral Cobalt Coordination Microparticles for Targeted Inflammatory Bowel Disease Treatment. ACS applied bio materials · 9 Jun 2026 PMID 42263142
  7. Glutathione-Induced In Situ Oxygen Vacancies in FeOOH Nanospindles for Boosting Sonocatalytic Tumor Therapy. Angewandte Chemie (International ed. in English) · 9 Jun 2026 PMID 42261917
  8. IR783-enabled thioketal-bridged paclitaxel nanoprodrugs with ROS-responsive release for tumor imaging and chemotherapy. Journal of photochemistry and photobiology. B, Biology · 27 May 2026 PMID 42202709
  9. Long-Acting Dynamic Therapy Using X-Ray Activated Organic Nanoparticles for Afterglow Imaging Guided Deep Tumor Treatment. Angewandte Chemie (International ed. in English) · 23 May 2026 PMID 42175828
Redox Regulation Across Disease (8)
  1. Ursolic acid ameliorates metabolic dysfunction-associated fatty liver disease by regulating the NOX4/ROS/NLRP3 pathway. Naunyn-Schmiedeberg's archives of pharmacology · 5 Oct 2026 PMID 42834206
  2. HIF1α-KLF4 signaling dictates extra-erythrocyte expression of hemoglobin conferring sorafenib resistance in hepatocellular carcinoma. Signal transduction and targeted therapy · 15 Sept 2026 PMID 42744801
  3. p-Coumaric acid inhibits hepatocellular carcinoma through promoting ROS accumulation. Medical oncology (Northwood, London, England) · 10 Sept 2026 PMID 42720830
  4. Early high‑frequency spinal cord stimulation modulates the ROS/p38 MAPK/NF‑κB and CXCL10/CXCR3 pathways to alleviate neuropathic pain and promote spinal cord injury repair. International journal of molecular medicine · 14 Aug 2026 PMID 42596832
  5. Structure-Property Relationship Analysis of α-Keto Ester Prodrugs of Monomethyl Fumarate as NRF2 Activators. ACS chemical neuroscience · 7 Jul 2026 PMID 42412905
  6. Cryptotanshinone Targets Ferroptosis in Glioma via the EGFR/ROS Signaling Pathway. Neurochemical research · 25 Jun 2026 PMID 42348047
  7. Autophagy-ferroptosis crosstalk in sepsis: metabolic pathways, redox injury, and host-directed antioxidant nanomedicine. Frontiers in immunology · 12 Jun 2026 PMID 42282965
  8. A Lipid-Conjugation Strategy for Intracellular Reactive Oxygen Species Control in Hepatic Cells. Angewandte Chemie (International ed. in English) · 11 Jun 2026 PMID 42275385
ROS-Based Cancer and Infection Therapy (7)
  1. De Novo Design of Multi-Mechanistic AIE Photosensitizer for Broad-Spectrum Bacterial Eradication. Journal of medicinal chemistry · 12 Nov 2026 PMID 43018578
  2. SUMOylated Reptin maintains low intracellular ROS levels by activating mitophagy to drive gemcitabine resistance in gallbladder cancer. Cell death & disease · 9 Sept 2026 PMID 42716921
  3. Intermolecular Noncovalent Locks Enable Red-Shifted Emission, Modulated Reactive Oxygen Species Generation Pathway, and Shuttle-Like Nanoassembly for Phototheranostics. ACS nano · 18 Aug 2026 PMID 42611238
  4. Lysosome-targeting naphthalimide-based AIEE nanoaggregates as a dual inducer of autophagy and apoptosis in cancer therapy. Nanoscale · 20 Jul 2026 PMID 42475021
  5. Mechanotherapeutic biomaterials: Overcoming physical barriers to enhance intratumoral drug delivery in solid tumours. Biomedical microdevices · 23 Jun 2026 PMID 42334617
  6. Santamarine Synergizes With Cisplatin via ROS/JNK Axis to Selectively Induce Apoptosis and DNA Damage in Oral Cancer Cells In Vitro. Drug development research · 26 May 2026 PMID 42187533
  7. Organelle-Targeted Photosensitizers for Enhanced Photodynamic Therapy of Cancer. Bioconjugate chemistry · 26 May 2026 PMID 42186767
Antioxidant Nanotherapy for Oxidative Stress (6)
  1. Mitochondria-targeted ROS-scavenging nanoreactor with dual-drug-loaded carbon dots for osteoarthritis therapy. Journal of materials chemistry. B · 15 Oct 2026 PMID 42876417
  2. Intrinsically Strain-Stiffening, Conductive, ROS-Scavenging Peptide-Polymer Hydrogel to Promote Neurite Outgrowth. Biomacromolecules · 14 Sept 2026 PMID 42734266
  3. Clioquinol-Loaded UiO-66(Ce) Metal-Organic Frameworks for Dual Reactive Oxygen Species Scavenging and Metal Chelation in Alzheimer's Disease. ACS applied bio materials · 17 Aug 2026 PMID 42606055
  4. Bone-targeted Mn3O4 nanozymes alleviate osteoporosis by remodeling the age-related oxidative stress microenvironment. Biomaterials science · 22 Jul 2026 PMID 42484352
  5. ROS produced in mitochondria entrapped by self-assembly peptide fibers for target therapy of glioma. Proceedings of the National Academy of Sciences of the United States of America · 15 Jul 2026 PMID 42455661
  6. Macrophage-amplified toxicity of indium tin oxide nanoparticles to bronchial epithelial cells involving ROS-associated NF-κB signaling. Toxicology · 27 May 2026 PMID 42203026
Smart Therapy for Diabetic Wounds (4)
  1. A dual-responsive nanosystem for synergistic antibacterial therapy and inflammatory microenvironment modulation in infected diabetic wound healing. Biomaterials science · 11 Aug 2026 PMID 42578380
  2. Multi-modular responsive hydroxypropyl chitosan-based hydrogel microspheres for stage-specific therapy in infected wounds. Carbohydrate polymers · 23 Jul 2026 PMID 42493128
  3. Nanoparticle-Cross-Linked Smart Responsive Hydrogels for Antimicrobial, Anti-Inflammatory, and Antioxidant Treatment of Diabetic Wounds. Biomacromolecules · 21 Jul 2026 PMID 42479468
  4. A GSH-scavenging and synthesis-blocking microneedle patch for augmenting photodynamic eradication of diabetic wound biofilms. Journal of materials chemistry. B · 16 Jun 2026 PMID 42300219

By study type

Human data, design not indexed (2)
  1. A Lipid-Conjugation Strategy for Intracellular Reactive Oxygen Species Control in Hepatic Cells. Angewandte Chemie (International ed. in English) · 11 Jun 2026 PMID 42275385
  2. Glutathione-Induced In Situ Oxygen Vacancies in FeOOH Nanospindles for Boosting Sonocatalytic Tumor Therapy. Angewandte Chemie (International ed. in English) · 9 Jun 2026 PMID 42261917
Preclinical: animal, cell and lab studies (31)
  1. De Novo Design of Multi-Mechanistic AIE Photosensitizer for Broad-Spectrum Bacterial Eradication. Journal of medicinal chemistry · 12 Nov 2026 PMID 43018578
  2. Mitochondria-targeted ROS-scavenging nanoreactor with dual-drug-loaded carbon dots for osteoarthritis therapy. Journal of materials chemistry. B · 15 Oct 2026 PMID 42876417
  3. HIF1α-KLF4 signaling dictates extra-erythrocyte expression of hemoglobin conferring sorafenib resistance in hepatocellular carcinoma. Signal transduction and targeted therapy · 15 Sept 2026 PMID 42744801
  4. Intrinsically Strain-Stiffening, Conductive, ROS-Scavenging Peptide-Polymer Hydrogel to Promote Neurite Outgrowth. Biomacromolecules · 14 Sept 2026 PMID 42734266
  5. p-Coumaric acid inhibits hepatocellular carcinoma through promoting ROS accumulation. Medical oncology (Northwood, London, England) · 10 Sept 2026 PMID 42720830
  6. SUMOylated Reptin maintains low intracellular ROS levels by activating mitophagy to drive gemcitabine resistance in gallbladder cancer. Cell death & disease · 9 Sept 2026 PMID 42716921
  7. Ultrasmall Ag₂Se@Mn quantum dots enable dual-modal imaging-guided early detection and antioxidant therapy of acute kidney injury. Mikrochimica acta · 7 Sept 2026 PMID 42704498
  8. Multiphoton imaging-guided and feedback-enabled anti-inflammatory therapy over MOF nanoplatforms. Journal of materials chemistry. B · 1 Sept 2026 PMID 42676025
  9. Intermolecular Noncovalent Locks Enable Red-Shifted Emission, Modulated Reactive Oxygen Species Generation Pathway, and Shuttle-Like Nanoassembly for Phototheranostics. ACS nano · 18 Aug 2026 PMID 42611238
  10. Clioquinol-Loaded UiO-66(Ce) Metal-Organic Frameworks for Dual Reactive Oxygen Species Scavenging and Metal Chelation in Alzheimer's Disease. ACS applied bio materials · 17 Aug 2026 PMID 42606055
  11. Early high‑frequency spinal cord stimulation modulates the ROS/p38 MAPK/NF‑κB and CXCL10/CXCR3 pathways to alleviate neuropathic pain and promote spinal cord injury repair. International journal of molecular medicine · 14 Aug 2026 PMID 42596832
  12. ROS-Triggered Disassembly of Nanoparticle-Networked Hydrogels Enables Dynamic Gating of Corneal Tight Junctions. ACS applied materials & interfaces · 13 Aug 2026 PMID 42587441
  13. Nitric Oxide-Releasing Molecular Co-Assembly Enables Epithelial-Mesenchymal Transition Suppression and Intermolecular Electron Transfer-Enhanced Type-I Photodynamic Therapy. ACS nano · 11 Aug 2026 PMID 42579410
  14. A dual-responsive nanosystem for synergistic antibacterial therapy and inflammatory microenvironment modulation in infected diabetic wound healing. Biomaterials science · 11 Aug 2026 PMID 42578380
  15. Multi-modular responsive hydroxypropyl chitosan-based hydrogel microspheres for stage-specific therapy in infected wounds. Carbohydrate polymers · 23 Jul 2026 PMID 42493128
  16. Bone-targeted Mn3O4 nanozymes alleviate osteoporosis by remodeling the age-related oxidative stress microenvironment. Biomaterials science · 22 Jul 2026 PMID 42484352
  17. Nanoparticle-Cross-Linked Smart Responsive Hydrogels for Antimicrobial, Anti-Inflammatory, and Antioxidant Treatment of Diabetic Wounds. Biomacromolecules · 21 Jul 2026 PMID 42479468
  18. Lysosome-targeting naphthalimide-based AIEE nanoaggregates as a dual inducer of autophagy and apoptosis in cancer therapy. Nanoscale · 20 Jul 2026 PMID 42475021
  19. ROS produced in mitochondria entrapped by self-assembly peptide fibers for target therapy of glioma. Proceedings of the National Academy of Sciences of the United States of America · 15 Jul 2026 PMID 42455661
  20. Structure-Property Relationship Analysis of α-Keto Ester Prodrugs of Monomethyl Fumarate as NRF2 Activators. ACS chemical neuroscience · 7 Jul 2026 PMID 42412905
  21. Cryptotanshinone Targets Ferroptosis in Glioma via the EGFR/ROS Signaling Pathway. Neurochemical research · 25 Jun 2026 PMID 42348047
  22. Mechanotherapeutic biomaterials: Overcoming physical barriers to enhance intratumoral drug delivery in solid tumours. Biomedical microdevices · 23 Jun 2026 PMID 42334617
  23. A GSH-scavenging and synthesis-blocking microneedle patch for augmenting photodynamic eradication of diabetic wound biofilms. Journal of materials chemistry. B · 16 Jun 2026 PMID 42300219
  24. Autophagy-ferroptosis crosstalk in sepsis: metabolic pathways, redox injury, and host-directed antioxidant nanomedicine. Frontiers in immunology · 12 Jun 2026 PMID 42282965
  25. Near-infrared light-triggered, self-amplifying targeted drug-delivery platform achieves precision treatment of retinoblastoma. International journal of pharmaceutics · 10 Jun 2026 PMID 42269794
  26. Oral Cobalt Coordination Microparticles for Targeted Inflammatory Bowel Disease Treatment. ACS applied bio materials · 9 Jun 2026 PMID 42263142
  27. Macrophage-amplified toxicity of indium tin oxide nanoparticles to bronchial epithelial cells involving ROS-associated NF-κB signaling. Toxicology · 27 May 2026 PMID 42203026
  28. IR783-enabled thioketal-bridged paclitaxel nanoprodrugs with ROS-responsive release for tumor imaging and chemotherapy. Journal of photochemistry and photobiology. B, Biology · 27 May 2026 PMID 42202709
  29. Santamarine Synergizes With Cisplatin via ROS/JNK Axis to Selectively Induce Apoptosis and DNA Damage in Oral Cancer Cells In Vitro. Drug development research · 26 May 2026 PMID 42187533
  30. Organelle-Targeted Photosensitizers for Enhanced Photodynamic Therapy of Cancer. Bioconjugate chemistry · 26 May 2026 PMID 42186767
  31. Long-Acting Dynamic Therapy Using X-Ray Activated Organic Nanoparticles for Afterglow Imaging Guided Deep Tumor Treatment. Angewandte Chemie (International ed. in English) · 23 May 2026 PMID 42175828
Unclassified: not yet indexed with MeSH (1)
  1. Ursolic acid ameliorates metabolic dysfunction-associated fatty liver disease by regulating the NOX4/ROS/NLRP3 pathway. Naunyn-Schmiedeberg's archives of pharmacology · 5 Oct 2026 PMID 42834206